A Study of ZG005 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
QTX3034 in Patients With KRAS G12D Mutation
- Status
- RECRUITING
- Phase
- PHASE1
CTS2190 Phase I /II Clinical Study in Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
- Status
- RECRUITING
- Phase
- PHASE1
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of ADRX-0706 in Select Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Expanded Access to Telisotuzumab Adizutecan
- Status
- AVAILABLE
- Phase
- N/A
An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer
- Status
- RECRUITING
- Phase
- PHASE2
MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1